The estimated Net Worth of Ventures Llc Remeditex is at least $208 Million dollars as of 30 June 2020. Ventures Remeditex owns over 120,481 units of Soliton stock worth over $208,058,375 and over the last 10 years Ventures sold SOLY stock worth over $0.
Ventures has made over 4 trades of the Soliton stock since 2018, according to the Form 4 filled with the SEC. Most recently Ventures bought 120,481 units of SOLY stock worth $999,992 on 30 June 2020.
The largest trade Ventures's ever made was buying 357,143 units of Soliton stock on 19 June 2019 worth over $8,064,289. On average, Ventures trades about 91,613 units every 111 days since 2014. As of 30 June 2020 Ventures still owns at least 9,214,277 units of Soliton stock.
You can see the complete history of Ventures Remeditex stock trades at the bottom of the page.
Ventures's mailing address filed with the SEC is 2727 N Harwood St #200, Dallas, TX 75201, USA.
Over the last 5 years, insiders at Soliton have traded over $0 worth of Soliton stock and bought 632,904 units worth $999,992 . The most active insiders traders include Walter V Klemp, Ventures Llc Remeditex und Jonathan P. Foster. On average, Soliton executives and independent directors trade stock every 126 days with the average trade being worth of $4,763,657. The most recent stock trade was executed by Ventures Llc Remeditex on 30 June 2020, trading 120,481 units of SOLY stock currently worth $999,992.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
Soliton executives and other stock owners filed with the SEC include: